Most medical device companies begin with an engineer's concept and then search for a clinical problem to match it. RC Medical, a medical device venture studio based in Lake Forest, California, operates in the opposite direction. "We go to the interventional suite first," says David Ferrera, CEO of RC Medical. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing."
This physician-first approach is central to RC Medical's venture studio model, which funds, designs, develops, and commercializes products specifically for the interventional radiology market. Rather than taking on contract work for outside clients, the studio partners directly with physician-entrepreneurs to identify new technology and new indications for devices, then forms a standalone company to carry each idea forward.
The relationship between RC Medical and physicians is framed as a partnership that extends from the first sketch through commercialization. "A physician knows the problem better than anyone," Ferrera says. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone." This division of labor allows the physician to remain close to the clinical need while RC Medical manages product development, funding, and the business structure required for commercialization.
When an idea clears the early evaluation stage, RC Medical does not fold it into an existing product line. Instead, it forms a new company around it. "Each idea gets its own company, its own team, its own focus," Ferrera says. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." That approach has already produced three separate companies: Single Pass, Infinity Neuro, and Sonorous NV. Each grew out of a specific problem a physician described in the interventional suite, and each operates as its own business rather than a product line inside RC Medical.
Ferrera brings close to three decades of experience building devices for interventional neuroradiology and related fields, including his time as a co-founder of Blockade Medical and as Chief Technology Officer of Balt Global. He says the lesson that carries over to RC Medical is simple: physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he says. "That detail doesn't show up unless you're building with the physician, not for them." The studio model is designed to catch that detail early, before a device design is locked in and hard to change.
Ferrera is candid that the studio is not the right fit for every idea. "Some ideas are better as a feature of an existing product, not a new company," he says. "Part of the first conversation is being honest about which one this is." For the ideas that do become a newco, the physician's involvement typically continues as the product moves through development and toward the market, keeping the clinical need in view at every stage rather than only at the start.
The implications for interventional radiology are significant. By structuring innovation around physician-identified gaps and giving each promising idea its own dedicated company, RC Medical's venture studio model could accelerate the translation of clinical insight into commercially viable devices. It also offers a template for how medical device innovation might better align with the realities of clinical practice, potentially reducing the risk that subtle but critical anatomical challenges are overlooked in device design.
